ASX:COH Cochlear (COH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cochlear Stock (ASX:COH) 30 days 90 days 365 days Advanced Chart Get Cochlear alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume201,277 shsAverage VolumeN/AMarket CapitalizationA$19.88 billionP/E Ratio55.90Dividend Yield1.35%Price TargetN/AConsensus RatingN/A Company Overview Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia. Read More Receive COH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COH Stock News HeadlinesCochlear Director Acquires Additional Shares, Signaling ConfidenceAugust 27 at 2:50 AM | tipranks.comCochlear earnings: Shares overvalued as demand softensAugust 19, 2025 | morningstar.com.auMTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all. Even crazier, this secret accurately called every major financial event in recent history … Now it's signaling something very scary is about to hit the market again …August 28 at 2:00 AM | Weiss Ratings (Ad)Cochlear Limited Reports FY25 Growth and Launches Innovative Implant SystemAugust 15, 2025 | msn.comCochlear Limited Announces 2025 AGM DetailsAugust 14, 2025 | theglobeandmail.comCochlear FY25 earnings: revenue and profit climb, dividend up 5%August 14, 2025 | msn.comCochlear Limited Releases 2025 Tax Contribution ReportAugust 14, 2025 | msn.comAre Cochlear Limited (ASX:COH) Investors Paying Above The Intrinsic Value?August 8, 2025 | finance.yahoo.comSee More Headlines COH Stock Analysis - Frequently Asked Questions How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) announced its earnings results on Tuesday, February, 19th. The company reported $2.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.19 by $0.04. Cochlear had a net margin of 15.80% and a trailing twelve-month return on equity of 19.70%. What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include CSL (CSL), ResMed (RMD), NIB (NHF), Accent Group (AX1), Corporate Travel Management (CTD), Mineral Resources (MIN) and Technology One (TNE). Company Calendar Last Earnings2/19/2019Today8/28/2025Ex-Dividend for 10/12 Dividend9/17/2025Record date for 10/12 Dividend10/12/2025Dividend Payable10/12/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:COH CIKN/A Webwww.cochlear.com Phone+61-2-94286555FaxN/AEmployees4,996Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$5.43 Trailing P/E Ratio55.90 Forward P/E RatioN/A P/E Growth3.87Net IncomeA$356.80 million Net Margins15.80% Pretax MarginN/A Return on Equity19.70% Return on Assets11.99% Debt Debt-to-Equity Ratio13.24 Current Ratio2.30 Quick Ratio1.93 Sales & Book Value Annual SalesA$2.24 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow123.45 Book ValueA$28.10 per share Price / BookN/AMiscellaneous Outstanding Shares65,500,000Free FloatN/AMarket CapA$19.88 billion OptionableNot Optionable Beta0.47 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (ASX:COH) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access